» Articles » PMID: 30177968

Zebrafish As a Model for Obesity and Diabetes

Overview
Specialty Cell Biology
Date 2018 Sep 5
PMID 30177968
Citations 107
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity and diabetes now considered global epidemics. The prevalence rates of diabetes are increasing in parallel with the rates of obesity and the strong connection between these two diseases has been coined as "diabesity." The health risks of overweight or obesity include Type 2 diabetes mellitus (T2DM), coronary heart disease and cancer of numerous organs. Both obesity and diabetes are complex diseases that involve the interaction of genetics and environmental factors. The underlying pathogenesis of obesity and diabetes are not well understood and further research is needed for pharmacological and surgical management. Consequently, the use of animal models of obesity and/or diabetes is important for both improving the understanding of these diseases and to identify and develop effective treatments. Zebrafish is an attractive model system for studying metabolic diseases because of the functional conservation in lipid metabolism, adipose biology, pancreas structure, and glucose homeostasis. It is also suited for identification of novel targets associated with the risk and treatment of obesity and diabetes in humans. In this review, we highlight studies using zebrafish to model metabolic diseases, and discuss the advantages and disadvantages of studying pathologies associated with obesity and diabetes in zebrafish.

Citing Articles

The Zebrafish Model in Animal and Human Health Research.

Szychlinska M, Marino Gammazza A Int J Mol Sci. 2025; 26(5).

PMID: 40076570 PMC: 11900036. DOI: 10.3390/ijms26051945.


The Interplay of Genetic Predisposition, Circadian Misalignment, and Metabolic Regulation in Obesity.

Halder S, Melkani G Curr Obes Rep. 2025; 14(1):21.

PMID: 40024983 PMC: 11872776. DOI: 10.1007/s13679-025-00613-3.


Zebrafish as a Suitable Model for Utilizing the Bioactivity of Coumarins and Coumarin-Based Compounds.

Lachowicz-Radulska J, Widelski J, Nowaczynski F, Serefko A, Sobczynski J, Ludwiczuk A Int J Mol Sci. 2025; 26(4).

PMID: 40003910 PMC: 11855297. DOI: 10.3390/ijms26041444.


Drug screening for ischemic stroke using larvae and adult zebrafish model: a review.

Nayaka N, Adnyana I, Anggadiredja K, Wibowo I Lab Anim Res. 2025; 41(1):1.

PMID: 39743611 PMC: 11694438. DOI: 10.1186/s42826-024-00232-4.


Recent Advances of the Zebrafish Model in the Discovery of Marine Bioactive Molecules.

Liu C, Li J, Wang D, Liu J, Liu K, Li P Mar Drugs. 2024; 22(12).

PMID: 39728115 PMC: 11678508. DOI: 10.3390/md22120540.


References
1.
Moss J, Koustubhan P, Greenman M, Parsons M, Walter I, Moss L . Regeneration of the pancreas in adult zebrafish. Diabetes. 2009; 58(8):1844-51. PMC: 2712797. DOI: 10.2337/db08-0628. View

2.
Willemsen G, Ward K, Bell C, Christensen K, Bowden J, Dalgard C . The Concordance and Heritability of Type 2 Diabetes in 34,166 Twin Pairs From International Twin Registers: The Discordant Twin (DISCOTWIN) Consortium. Twin Res Hum Genet. 2015; 18(6):762-71. DOI: 10.1017/thg.2015.83. View

3.
Delaspre F, Beer R, Rovira M, Huang W, Wang G, Gee S . Centroacinar Cells Are Progenitors That Contribute to Endocrine Pancreas Regeneration. Diabetes. 2015; 64(10):3499-509. PMC: 4587647. DOI: 10.2337/db15-0153. View

4.
Hugo S, Cruz-Garcia L, Karanth S, Anderson R, Stainier D, Schlegel A . A monocarboxylate transporter required for hepatocyte secretion of ketone bodies during fasting. Genes Dev. 2012; 26(3):282-93. PMC: 3278895. DOI: 10.1101/gad.180968.111. View

5.
Lu D, Willard D, Patel I, Kadwell S, Overton L, Kost T . Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature. 1994; 371(6500):799-802. DOI: 10.1038/371799a0. View